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The SH gene of the paramyxovirus SV5 is located between the genes for the glycoproteins, fusion protein (F) and
hemagglutinin-neuraminidase (HN), and the SH gene encodes a small 44-residue hydrophobic integral membrane protein
(SH). The SH protein is expressed in SV5-infected cells and is oriented in membranes with its N terminus in the cytoplasm.
To study the function of the SH protein in the SV5 virus life cycle, the SH gene was deleted from the infectious cDNA clone
of the SV5 genome. By using the recently developed reverse genetics system for SV5, it was found that an SH-deleted SV5
(rSV5DSH) could be recovered, indicating the SH protein was not essential for virus viability in tissue culture. Analysis of
properties of rSV5DSH indicated that lack of expression of SH protein did not alter the expression level of the other virus
proteins, the subcellular localization of F and HN, or fusion competency as measured by lipid mixing assays and a new
content mixing assay that did not require the use of vaccinia virus. The growth rate, infectivity, and plaque size of rSV5 and
rSV5DSH were found to be very similar. Although SH is shown to be a component of purified virions by immunoblotting,
examination of purified rSV5DSH by electron microscopy did not show an altered morphology from SV5. Thus in tissue
culture cells the lack of the SV5 SH protein does not confer a recognizable phenotype. © 1998 Academic Press
INTRODUCTION
Simian virus 5 (SV5) is a member of the Rubulavirus
genus of the family Paramyxoviridae, a genus which in-
cludes mumps virus, human parainfluenza virus type 2
(HPIV2) and type 4 (HPIV4), and Newcastle disease virus
(NDV). Other members of the Paramyxoviridae include Sen-
dai virus, human parainfluenza virus type 3, measles virus,
canine distemper virus, rinderpest virus, and respiratory
syncytial (RS) virus. SV5 contains a negative-sense single-
stranded RNA of 15,246 nucleotides and encodes eight
known viral proteins: nucleocapsid protein (NP), V protein
and phosphoprotein (P), matrix protein (M), fusion protein
(F), small hydrophobic integral membrane protein (SH),
hemagglutinin-neuraminidase (HN), and polymerase pro-
tein (L). The P protein mRNA is synthesized through a
cotranscriptional RNA editing process in which two non-
templated G residues are inserted into the templated
mRNA transcript (Thomas et al., 1988). The NP, P, V, and L
proteins are associated with the RNA genome to form the
nucleocapsid core; these proteins form the viral transcrip-
tion/replication complex. The M protein is a peripheral
membrane protein, and the SH, F, and HN proteins are
integral membrane proteins. F and HN are involved in viral
entry into cells and HN is important for virus release from
cells (reviewed in Lamb and Kolakofsky, 1996).
The SV5 SH gene is located between the genes for F
and HN (Hiebert et al., 1985a,b). The SH protein contains
44 amino-acid residues, and in SV5-infected cells SH
protein is orientated in membranes with its N terminus in
the cytoplasm. SH protein contains a transmembrane
domain with a predicted length of 19 residues and an
ectodomain of 7 residues (Hiebert et al., 1985b, 1988).
The function of the SH protein in the SV5 life cycle is not
known, and it has not been determined previously if SH
is a component of virions.
The SH gene is not common to all members of the
Paramyxoviridae, and the only other virus that contains an
analogous gene located between the genes for F and HN
is the closely related Rubulavirus, mumps virus (Elango et
al., 1989; Takeuchi et al., 1996). In the Pneumovirus, respi-
ratory syncytial (RS) virus, a gene encoding a third integral
membrane protein, designated SH, has been identified
(Collins and Wertz, 1985; Olmsted and Collins, 1989). How-
ever, the RS virus SH protein is considerably larger than
that of SV5, and it is not known if the RS virus SH protein is
a functional counterpart of the SH protein. The RS virus SH
gene is lacking from an attenuated strain of RS virus (Karron
et al., 1997) and a recombinant RS virus lacking the SH
gene is viable in tissue culture (Bukreyev et al., 1997).
Recently, a reverse genetics system was developed for
SV5 such that infectious virus (rSV5) could be rescued from
cDNA (He et al., 1997): the scheme used was first de-
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scribed for rabies virus (Schnell et al., 1994) and subse-
quently has been extended to several members of the
Mononegavirale (reviewed in Roberts and Rose, 1998). To
study properties of the SH protein in the life cycle of SV5,
we have deleted the SH gene from the infectious cDNA and
have shown that even though SH is a component of virions,
a viable virus (rSV5DSH) can be rescued in tissue culture




The plasmid pSV5DSH was derived from the infectious
cDNA of SV5 (pSV5). The SH gene and the gene end (GE)
and gene start (GS) sequences between SH and HN were
deleted. The final genome length of pSV5DSH (15,012 nu-
cleotides) was designed such that the genome length was
a whole integer divisible by six to adhere to the ‘‘rule of six’’
(Calain and Roux, 1993). It was anticipated that rSV5DSH
transcription of the HN gene would use the SH gene start
sequences and thus the HN mRNA 59 nontranslated region
would be extended in length over that of rSV5. To recover
viruses, plasmids pSV5 and pSV5DSH were transfected,
together with the helper plasmids encoding NP, P, and L
proteins, into A 549 cells, which had been preinfected with
a modified vaccinia virus encoding a T7 RNA polymerase
gene (MVA). Recovery of viruses was performed as de-
scribed previously (He et al., 1997).
Recovery of rSV5DSH was indicated initially by the ob-
servation of syncytia in CV-1 cells after infection with the
supernatant from the transfected A549 cells. To confirm that
rSV5DSH was recovered, total RNAs were extracted from
CV-1 cells, and the RNAs subjected to RT–PCR using ap-
propriate primers as indicated in Fig. 1. Cells transfected
with pSV5 yielded a DNA fragment (576 bp) that was found
to be larger than the product from cells transfected with
pSV5DSH (342 bp) (Fig. 1, lanes 6 and 7). Appropriate
controls for the RT–PCR reaction were negative (Fig. 1,
lanes 1–5). The RT–PCR products from rSV5- and rSV5DSH-
infected cells were purified and their nucleotide sequence
obtained. The resulting sequences matched the pSV5 and
pSV5DSH plasmid sequences, confirming that rSV5 and
rSV5DSH had been recovered.
rSV5DSH mRNA synthesis
To examine transcription of the genome of SV5 and
rSV5DSH between the F and HN genes, the accumula-
tion of the F, SH, and HN mRNA in infected CV-1 cells
FIG. 1. Recovery of rSV5DSH. Top: Structure of the rSV5 and rSV5DSH genomes. The SH coding region and the GE/GS sequences between SH
and HN, which control termination, polyadenylation, and reinitiation of SV5 transcription, were deleted from an infectious cDNA of the SV5 genome.
As a result, transcription of the HN gene uses the GS sequence from the SH gene. Rescue of rSV5DSH was performed as described under Materials
and Methods. Bottom: RT–PCR of RNA from rSV5 and rSV5DSH virus-infected CV-1 cells using primers BH191 and BH194. The products were analyzed
on 1% agarose gels: lane 1, PCR control, which contained no template; lanes 2, 4, and 6, products from rSV5-infected cell; lanes 3, 5, and 7, products
from rSV5DSH-infected cells; lanes 2 and 3, RT control in which no RT was added in the RT reaction; lanes 4 and 5, PCR control in which no Taq DNA
polymerase was added; lanes 6 and 7, complete RT-PCR reaction; lane 8, DNA size marker with relevant sizes indicated.
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was examined by hybridization of purified poly(A)-con-
taining RNA, using a Northern blot analysis. As shown in
Fig. 2, hybridization with a probe specific for SH indi-
cated that the SH-specific mRNA was lacking from
rSV5DSH-infected cells, together with the F–SH and
SH–HN RNA readthrough products observed with SV5
(Fig. 2 and see Paterson et al., 1984). However, accumu-
lation of the F and HN mRNAs between SV5- and
rSV5DSH-infected cells appeared to be comparable. A
slightly slower mobility of the rSV5DSH HN mRNA was
discernible compatible with the HN mRNA of rSV5DSH
containing a longer 59 noncoding region than SV5 due to
construction of pSV5DSH.
rSV5DSH protein synthesis
To examine viral-specific protein accumulation, CV-1
cells were infected with SV5, rSV5, and rSV5DSH and met-
abolically labeled with [35S]-Promix, cells lysed and pro-
FIG. 3. Protein expression in rSV5- and rSV5DSH-infected cells.
Mock-infected and SV5-, rSV5-, and rSV5DSH-infected CV-1 cells were
metabolically labeled with 100 mCi/ml of [35S]-Promix for 2 h at 22 h p.i.
and cell lysates were prepared for immunoprecipitation reactions. (A)
Immunoprecipitation using a rabbit sera prepared against disrupted
SV5 virions. (B) Immunoprecipitation using sera specific for HN, SH, F2,
P, and V (see Materials and Methods).
FIG. 4. (Top) Immunofluorescent staining patterns of rSV5- and rSV5DSH-infected cells. CV-1 cells on coverslips were mock infected or infected
with rSV5 or rSV5DSH and at 24 h p.i. were fixed with 1% formaldehyde and permeabilized with 0.1% saponin. Cells were stained with mouse mAbs
specific for F and HN and rabbit polyclonal sera specific for SH and FITC-conjugated goat anti-mouse or Texas-Red-conjugated goat anti-rabbit
secondary antibody. Fluorescence was examined using a Nikon FXA fluorescent microscope and appropriate filter sets.
FIG. 5. (Middle and bottom) Fusion activity of rSV5- and rSV5DSH-infected cells. (A) Lipid mixing assay. Octadecyl rhodamine (R18)-labeled RBCs
were overlaid on SV5-infected CV-1 cells at 4°C. The temperature was shifted to 37°C and after 0, 5, and 15 min the transfer of R18 to the CV-1 cells
was examined by confocal microscopy. (B) Content mixing assay. One set of BHK-21F cells in six-well plates were infected with rSV5 or rSV5DSH for
1 h and then transfected with plasmid pYZ3, which encodes bacteriophage T7 RNA polymerase under the control of the SV40 late region promoter.
A second set of BHK-21F cells on 6-cm-diameter plates was transfected with pBH82, which encodes the CAT gene under the control of a T7 RNA
polymerase promoter. After 10 h incubation the pBH82-transfected cells were trypsinized and overlaid on the pYZ3-transfected cells. At 4, 8, and 12 h
after mixing the cells were harvested and CAT protein activity was measured as described under Materials and Method. CAT activity is in arbitrary
units; N 5 3.
FIG. 2. Northern blot of SV5- and rSV5DSH-infected cell RNA. Poly(A)-
containing RNA species from SV5- and rSV5DSH-infected cells were
isolated on oligo-(dT) cellulose and separated by electrophoresis on a
1.5% agarose/2.2 M formaldehyde gel and transferred to a nitrocellu-
lose membrane as described under Material and Methods. Left: 32P-
labeled cDNA probes specific for both the F and SH genes were
hybridized to the filter. Right: 32P-labeled probes specific for HN and SH
were hybridized to the filter. The mRNAs for HN, F, and SH are shown
and the identity of the readthrough transcripts, M–F, F–SH, and SH–F is
based on their expected mobilities as compared to size markers (not
shown). A slightly slower mobility of HN mRNA from rSV5DSH-infected
cells is a result of the altered GS sequence (see Fig. 1).
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teins immunoprecipitated with specific antisera. As shown
in Fig. 3A, when a serum generated to disrupted SV5 virions
was used, the overall polypeptide pattern observed among
viruses was indistinguishable. The use of specific sera for
HN, F2, P, and V indicated similar levels of accumulation of
these proteins, and the use of SH-specific sera indicated
that whereas SH protein could be identified in SV5- and
rSV5-infected cells, it could not be identified in rSV5DSH-
infected cells (Fig. 3B).
Deletion of the SH gene does not affect the
subcellular localization of F and HN or affect virus-
mediated fusion
The SV5 F protein only requires HN for cell attachment
purposes, unlike many other paramyxoviruses, which
require the action of their homotypic HN protein for a
fusion reaction to proceed (reviewed in Lamb, 1993).
However, a possible role of the SH protein in participat-
ing in the fusion reaction had not been tested rigorously.
For RS virus, the SH protein had been shown to be
required for the fusion reaction using in vitro assays
(Heminway et al., 1994); however, a viable RS virus lack-
ing the SH gene has been recovered (Bukreyev et al.,
1997). To test for a possible effect of the SV5 SH protein
on the fusion reaction, the intracellular staining patterns
of SH, F, and HN were examined. Immunofluorescent
staining of F, SH, and HN proteins in rSV5 and rSV5DSH
virus-infected cells were all comparable, indicating that
SH protein expression did not cause a subcellular relo-
calization of the F and HN proteins (Fig. 4). Furthermore,
analysis of the amounts of F and HN at the surface of
rSV5- and rSV5DSH-infected cells by flow cytometry in-
dicated comparable surface expression levels of the two
glycoproteins (Table 1).
To examine an affect of deletion of the SH gene from
SV5 on fusion, both lipid and content mixing assays were
performed. In the lipid mixing assay, the fluorescent dye
octadecyl rhodamine (R18), contained in human erythro-
cyte membranes, was transferred to the membranes of
CV-1 cells infected with rSV5 or rSV5DSH. Observation of
the time course of dye transfer to the CV-1 cells, by
confocal microscopy, indicated a lack of a discernible
difference between rSV5- and rSV5DSH-infected cells
(Fig. 5A).
To examine mixing of the aqueous contents of the
cytoplasm of two cells upon fusion, we developed a new
assay. The established assay involving transfection of a
plasmid encoding b-galactosidase, under the control of a
bacteriophage T7 RNA polymerase promoter, into one
cell and expression of T7 RNA polymerase (from a re-
combinant vaccinia virus) in another cell has proven very
useful when fusion proteins are expressed from cDNAs
(Nussbaum et al., 1994; Bagai and Lamb, 1995–1997).
However, we were concerned about the cytopathic effect
of vaccinia virus coinfection on SV5-infected cells. Thus
we modified the established assay such that BHK-21F
cells were infected with rSV5 or rSV5DSH and then
transfected with pYZ3, a plasmid that encodes a gene for
T7 RNA polymerase under the control of the SV40 late
region promoter and polyadenylation signal. A second
batch of BHK-21F cells were transfected concomitantly
with pBH82, a plasmid encoding chloramphenicol acetyl-
transferase (CAT) under the control of a T7 RNA poly-
merase promoter and an internal ribosome entry site
(EMCV–IRES). At 8–10 h posttransfection, the pBH82-
transfected cells were trypsinized and overlaid onto the
pYZ3-transfected/SV5-infected cells At 4, 8, and 12 h
postmixing of the cells, CAT activity was measured. As
shown in Fig. 5B, CAT activity, which is indicative of
cytoplasmic content mixing, was very similar for rSV5
and rSV5DSH virus-infected cells.
SH protein is a component of purified SV5 virions
As SH is an integral membrane protein expressed at
the surface of virus-infected cells (Hiebert et al., 1988), it
seemed likely that SH would be incorporated into bud-
ding particles, unless a mechanism exists for excluding
its presence from virions. To determine whether SH pro-
tein is a component of virions, rSV5 and rSV5DSH were
grown in MDBK cells, purified on sucrose gradients, and
their polypeptide composition analyzed by SDS–PAGE.
Polypeptides were immunoblotted using anti-SH IgG
and, as a control for known virion components, were
immunoblotted with sera specific for HN, P, and V pro-
teins. As shown in Fig. 6, SH protein could be readily
detected in rSV5 virions. Attempts to show the presence
of SH in virions, using metabolic labeling of virions, as
had been used to show the presence of the M2 protein in
influenza A virions (Zebedee and Lamb, 1988) were un-
successful. However, SH protein only contains a single
TABLE 1
Mean Fluorescence Intensity (MFI) of F and HN Proteins in CV-1
Cells Infected with rSV5 and rSV5DSH
Glycoprotein rSV5 MFI rSV5DSH MFI
F 706 6 60 601 6 10
HN 171 6 15 146 6 5
Note. rSV5 and rSV5DSH virus-infected CV-1 cells at 18 h p.i. were
washed three times with phosphate-buffered saline deficient in cal-
cium and magnesium and 0.02% sodium azide (PBS–FACS). The cells
were incubated with the F-specific mAb F1a (1:1000 dilution of ascites
fluid) (Randall et al., 1987) and rabbit anti-HN polyclonal antibody (1:300
dilution) for 30 min on ice. The cells were then washed with PBS–FACS
as described above and incubated with a goat anti-rabbit fluorescein
isothiocyanate-conjugated secondary antibody and a goat anti-mouse
Texas-Red-conjugated secondary antibody for 30 min. The cells were
washed a further three times with PBS–FACS and fixed in 0.5% form-
aldehyde. F- and HN-specific fluorescence on the aliquots were mea-
sured on 10,000 cells using a FACSCalibur (Becton-Dickinson, San
Jose, CA) flow cytometer. Values are means 6 SD.
34 HE ET AL.
methionine residue and no cysteine residues, which lim-
its the usefulness of high specific activity radioactive
metabolic precursors. To determine the amount of the M2
protein in influenza A virions or the NB protein in influ-
enza B virions, we have used a quantitative immunoblot
method in which the signal from known amounts of
purified virions was compared to that of known amounts
of purified M2 or NB protein (Zebedee and Lamb, 1988;
Brassard et al., 1996). However, for SH we have not
succeeded in generating a high-titer antisera useful for
affinity purification of the protein, and we have not suc-
ceeded in generating an epitope-tagged version of SH
that is expressed at the cell surface (C. D. Ward and R. A.
Lamb, unpublished data). Thus it is not possible to quan-
tify the relative incorporation of SH into virions at present.
Examination of purified rSV5 and rSV5DSH virions by
electron microscopy indicated that for the .300 particles
of each virus examined, the morphologies of the virions
were indistinguishable (Fig. 7). Ideally it would useful to
show, in addition to immunoblotting, that SH protein is
contained in virions using immunoelectron microscopy.
However, the only serum that is available to the SH
protein is the anti-SH IgG, which recognized a peptide
encompassing the SH N-terminal cytoplasmic tail
(Hiebert et al., 1985b, 1988). The SH ectodomain contains
only five residues, a size too small to permit generation
of a specific serum. Thus examination of rSV5 and
rSV5DSH by immunoelectron microscopy has to involve
detergent disruption of virions on the E.M. grid. Unfortu-
nately, the experiment was not successful due to a low
signal and nonspecific binding of the SH IgG to rSV5DSH
virions.
FIG. 7. Morphology of rSV5 and rSV5DSH. Purified rSV5 and rSV5DSH virions were absorbed onto electron microscopy grids and negatively stained
with phosphotungstic acid. (A) rSV5, (B) rSV5DSH. Examination of .300 virions of rSV5 and rSV5DSH indicated no evident morphological differences
between the two virus populations. Bar, 50 mm.
FIG. 6. Western blot of purified rSV5 and rSV5DSH virions. rSV5 and
rSV5DSH were grown in MDCK cells and purified through sucrose
gradients. Virions were analyzed by SDS–PAGE on a 17.5% gel contain-
ing 4 M urea, and polypeptides were transferred to a nitrocellulose
membrane. The blots were incubated with rabbit anti-SH IgG (left) or
mouse anti-HN and anti-V/P sera (right) and appropriate HRP-conju-
gated secondary antibodies. Bound HRP was detected by an enhanced
chemiluminescent reaction.
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Growth rate of rSV5DSH
The growth rates of rSV5 and rSV5DSH were com-
pared in a single-step growth curve experiment. MDBK
cells were infected with the viruses at a m.o.i. of 10
pfu/cell, the media were harvested at varying times, and
virus titers were measured by plaque assay. No differ-
ence in plaque size between rSV5 and rSV5DSH was
observed (Fig. 8A), and rSV5 and rSV5DSH showed very
similar growth curves (Fig. 8B).
DISCUSSION
The data presented here indicate that it is possible to
rescue the paramyxovirus SV5 when it lacks its SH gene.
Analysis of properties of the rSV5DSH virus indicated
that deletion of the SH gene did not affect transcription of
the F and HN genes, except that readthrough mRNAS
(F–SH and SH–HN) could not be detected as would be
predicted for a SH gene deletion. The lack of expression
of the SH integral membrane protein did not alter the
expression levels of other viral proteins that were exam-
ined (P, V, F, and HN) or the subcellular localization of the
F and HN integral membrane proteins. Furthermore, lack
of expression of SH did not affect the ability of the virus
to cause fusion as measured by lipid mixing experiments
and content mixing experiments. The growth rate, infec-
tivity, and plaque size of rSV5DSH indicated that these
properties of the virus were directly comparable to those
of rSV5. We also found that even though the SH protein
is a component of purified SV5 virions, the lack of SH
from rSV5DSH does not alter the morphology of the virus
particles. Thus in tissue culture cells, the lack of the SV5
SH protein does not confer a recognizable phenotype.
However, the evolution of the GS and GE signals for SH
indicates this is a specific transcription unit in the SV5
genome and not a residual vestige of a pseudogene.
Thus it seems quite possible that the absence of the SH
protein would confer a phenotype in an appropriate an-
imal host. SV5 is naturally a pathogen of dogs, causing
kennel cough, but SV5 has also been isolated from
monkeys, pigs, and humans (Choppin, 1964; Hull et al.,
1956; Goswami et al., 1984; and Hans-Dieter Klenk, per-
sonal communication). However, unfortunately at present
a small animal model that is fully permissive for the in
vivo study of pathogenesis is not available and the use of
large animals is not fiscally feasible.
Among the Paramyxovirinae, only SV5 and mumps
virus have SH genes (Hiebert et al., 1985a,b, 1988;
Elango et al., 1989; Takeuchi et al., 1991, 1996; Afzal et al.,
1993; Yeo et al., 1993; Kunkel et al., 1994, 1995), and the
closely related Rubulaviruses, hPIV2 (Kawano et al.,
1990), hPIV4 (Bando et al., 1990), and simian virus 41
(SV41) (Tsurudome et al., 1991) lack such a gene. Even
between SV5 and mumps virus there is a difference in
the SH proteins: although both SH proteins are small
integral membrane proteins (44 and 57 amino, respec-
tively), the available data suggest that the SV5 protein
has its N-terminal domain in the cytoplasm (Hiebert et
al., 1988), whereas the mumps virus SH protein has its C
terminus in the cytoplasm (Takeuchi et al., 1996). Further-
more, with the Enders strain of mumps virus, a point
mutation in the F-gene polyadenylation site leads to the
exclusion of monocistronic SH mRNA synthesis and pro-
duction of only F–SH and F–SH–HN polycistronic mRNAs
(Takeuchi et al., 1988), and there is no detectable expres-
sion of the SH protein (Takeuchi et al., 1996), suggesting
that the SH gene may not be essential in tissue culture
for the replication of the Enders strain of mumps virus.
However, it cannot be excluded that for the Enders strain
of mumps virus undetectable amounts of essential SH
mRNA and protein are synthesized.
The RS virus SH gene (originally named 1A) encodes
a glycosylated integral membrane protein (Olmsted and
Collins, 1989) that is often thought to be a counterpart of
the SV5 SH protein (reviewed in Collins et al., 1996). In
earlier reports, it was found that expression of SH was
required for efficient RS virus-mediated fusion when vi-
rus proteins were expressed from cDNAs using the vac-
cinia virus expression system (Heminway et al. 1994).
However, by using reverse genetics it was found possi-
ble to delete the SH gene and recover a viable virus
FIG. 8. Single-step growth curve of rSV5 and rSV5DSH. MDCK cells
were infected with rSV5 and rSV5DSH at a m.o.i. of 10 pfu/cell and
media harvested at 6-h intervals up to 36 h p.i. The virus titers were
determined by plaque assay on BHK 21-F cells. (A) Plaques of rSV5 and
rSV5DSH stained with Giemsa. (B). Growth curves of rSV5 and
rSV5DSH.
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(RSVDSH), and by a nonquantitative syncytium assay it
was found to cause fusion as efficiently as the parental
virus (Bukreyev et al., 1997). Interestingly, the RSVDSH
virus showed improved growth in some tissue culture
cells as compared to wild-type virus; however, the
RSVDSH virus was attenuated in the upper but not the
lower respiratory tract of mice (Bukreyev et al., 1997).
Furthermore a cold-passaged strain of RS virus, B1 cp-
52/2B5 has been found to contain a deletion of most of
the SH and G gene sequences, yet this virus replicates
quite efficiently in tissue culture cells although it is highly
attenuated in RS virus seronegative infants and children
(Karron et al., 1997).
Reverse genetics experiments using infectious cDNA
clones of several Mononegavirale suggest that these
viruses contain dispensable accessory proteins that are
not required for replication in tissue culture. Neither the
C protein of vesicular stomatitis virus (Kretzschmar et al.,
1996) nor the similar in name (but not necessarily in
function) C protein of measles virus (Schneider et al.,
1997) are required for replication in tissue culture but the
effect of these gene deletions in a suitable animal host
has not been tested to date. Recombinant Sendai virus
and measles virus that are unable to synthesize the V
protein have also been recovered, indicating the V pro-
tein is not essential for replication in tissue culture
(Delenda et al., 1997; Kato et al., 1997a; Schneider et al.,
1997). However, the Sendai virus V protein was found to
be essential for pathogenicity in the natural host, the
mouse (Kato et al., 1997a,b). Thus as the accessory
proteins of the Mononegavirale have been maintained in
all natural viral isolates, it seems likely that they will have
a role in determining viral pathogenesis in their respec-
tive host organisms even though an appropriate host




All molecular cloning procedures were carried out
according to standard procedures (Ausubel et al., 1994).
To generate pSV5DSH (pBH324), a DNA fragment
(nucleotides 6303–6536, GenBank Accession No.
AF052755) that covers the SH gene was deleted from the
infectious SV5 cDNA pSV5 (pBH276) (He et al., 1997). The
nucleotide sequence of all plasmids used is available on
request together with details on the construction of the
intermediate plasmids used to generate plasmids pSV5
and pSV5DSH. The genome length of pSV5DSH was
engineered to conform to the rule of six (Calain and
Roux, 1993) such that the total nucleotide number was
divisible by six. The nucleotide sequence of the region
covering the SH gene deletion was confirmed by dideoxy
chain terminating sequencing. Plasmids pUC19NP3A,
pGEM2-P, and pGEM3-L are those plasmids described
previously (Thomas et al., 1988; Parks et al., 1992; Mur-
phy and Parks, 1997). Plasmids containing the HN, F, and
SH genes that were used for generating 32P-labeled
probes have been described (Paterson et al., 1984;
Hiebert et al., 1985b; He et al., 1997). pYZ3 contains a
gene encoding bacteriophage T7 RNA polymerase under
control of the SV40 late region promoter and has been
described previously (Zhou et al., 1990). pBH82, which
contains a gene encoding CAT under the control of a T7
RNA polymerase promoter, control was described previ-
ously (He et al., 1995).
Cells and viruses
Monolayer cultures of A549, MDBK, and CV-1 cells
were maintained in DMEM and 10% fetal-calf serum as
described previously (He et al., 1997; Paterson et al.,
1984). Chick embryo fibroblasts (CEF) were grown as
described previously (Lamb and Choppin, 1976). BHK-
21F cells were grown in DMEM with 10% fetal-calf serum
and 10% tryptose phosphate broth.
Modified vaccinia virus Ankara (MVA) expressing bac-
teriophage T7 RNA polymerase (Sutter et al., 1995; Wyatt
et al., 1995) was grown in CEF cells and was kindly
provided by Dr. Bernard Moss, National Institutes of
Health, Bethesda, MD. SV5 was grown in MDBK cells
with DMEM containing 2% fetal-calf serum as described
previously (Paterson and Lamb, 1993).
For single-step growth curves, MDBK cells in 3.5-cm-
diameter dishes were infected with rSV5 or rSV5DSH at
a m.o.i. of 10 pfu/cell. Media was collected at 0, 6, 12, 18,
24, 30, and 36 h p.i. Viral titers were determined by
plaque assay on BHK-21F cells as described (Paterson
and Lamb, 1993).
Transfection of cDNAs encoding virus genomes and
recovery of rSV5 and rSV5DSH
A549 cells in a 3.5-cm-diameter plate were infected at
95% confluence with MVA at an m.o.i. of 3 pfu/cell in PBS
containing 1% bovine serum albumin for 1 h, and then the
plasmids pSV5, or pSV5DSH and those encoding NP, P,
and L were transfected into cells with the cationic lipid
Lipofectin (Gibco-BRL, Rockville, MD). The amounts of
plasmids were as follows: 1.5 mg pSV5, 1.2 mg pUC19
NP3A, 0.15 mg pGEM 2-P, and 1.5 mg pGEM 3-L. Infected/
transfected cultures were incubated for 24 h, and then
the transfection media was replaced with DMEM con-
taining 2% fetal-calf serum and incubated for a further
48 h at 37°C. The media were harvested, cell debris
pelleted by low speed centrifugation (1250 x g, 5 min),
and the supernatant filtered through a 0.45-mm filter to
remove MVA. This virus stock was designated Pl and
was used to generate further SV5 stocks in CV-1 cells or
MDBK cells. The virus was then clonally purified by
plaque assay.
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Reverse transcriptase–PCR amplification
Total RNA from rSV5- or rSV5DSH-infected CV-1 cells
(6-cm-diameter plates) was purified using an RNeasy kit
(Qiagen, Chatsworth, CA) according to the manufacturer’s
protocol. RNAs were dissolved in H2O in a final volume of
50 ml, and 19 ml was used in a 40-ml reverse transcriptase
(RT) reaction containing 20 ng of oligonucleotide primer
BH191 (sequence: 59-TATTGACCATTGTCGTTGCTAATCGA-
AA-39) that annealed to the vRNA(2) strand of SV5. An
aliquot of the cDNA was then amplified in a PCR reaction
using oligonucleotides BH191 and BH194 (sequence: 59-
TCGAAATAATACTCGGCAAGTGGCC-39), which anneals to
the anti-genome sense RNA of SV5 (see Fig. 1). PCR was
carried out at 94°C for 1 min, 55°C for 1 min, and 72°C for
1 min for 40 cycles. The PCR products were analyzed on a
1% agarose gel and purified for sequencing using an ABI
310 sequencer (Perkin-Elmer/Applied Biosystems, Foster
City, CA).
Northern blot analysis of mRNAs
Poly(A)-containing RNA from rSV5-infected CV-1
cells (10-cm-diameter dish) was purified as described
(Paterson et al., 1984) and separated by electrophore-
sis on a 1.5% agarose gel containing 2.2 M formalde-
hyde as described previously (Paterson et al. 1984).
RNAs were transferred to a nitrocellulose membrane
and crosslinked to the membrane by using UV irradi-
ation (UV Stratalinker 2400, Stratagene, La Jolla, CA).
a-[32P]-dCTP-labeled F, HN, or SH cDNA probes were
generated using a Ready-to-Go random priming kit
(Pharmacia Biotech, Piscataway, NJ). The membrane
was hybridized with the probes and then washed un-
der increasing stringency conditions (Paterson et al.,
1984). The bound probes were detected by autoradiog-
raphy.
Immunoprecipitation of polypeptides
CV-1 cells in 6-cm-diameter plates were infected with
wild-type SV5, rSV5, or rSV5DSH at a m.o.i. of 3 pfu/cell
and at 22 h p.i., cultures were labeled with 100 mCi/ml
[35S]Promix label (Amersham Life Science Products, Ar-
lington Heights, IL) for 2 h. The cells were lysed in RIPA
buffer, and aliquots were immunoprecipitated using mAb
HN4b specific for HN (Randall et al., 1987; Ng et al.,
1989), a-F2 synthetic peptide rabbit sera (Horvath and
Lamb, 1992), mAb 161 specific for P protein (Thomas et
al., 1988), a-V synthetic peptide rabbit sera (Paterson et
al., 1995), and polyclonal rabbit serum raised to disrupted
SV5 virions or rabbit anti-SH IgG (Hiebert et al., 1985b),
as described previously (Paterson and Lamb, 1993).
Polypeptides were analyzed by SDS–PAGE using 10 or
15% polyacrylamide gels, except for SH protein, which
was resolved on 17.5% polyacrylamide gels containing 4
M urea. Radioactivity was analyzed using a Fuji BioIm-
ager 1000 and MacBas software (Fuji Medical System,
Stamford, CT).
Fluorescent microscopy
CV-1 cells were grown on glass coverslips and in-
fected with rSV5 or rSV5DSH. At 24 h p.i. cells were
washed with PBS and then fixed in 1% formaldehyde for
15 min at room temperature. In all further steps, 0.1%
Saponin was included in the PBS to permeabilize cells.
The cells were washed with PBS/Saponin solution and
incubated for 30 min in a 1:500 dilution of ascites fluid to
mAb F1a specific for SV5 F protein, mAb HN1b specific
for the SV5 HN protein, and mAb Pk specific for the SV5
P and V proteins or rabbit a-SH IgG. Cells were washed
extensively in PBS/Saponin and the appropriate second-
ary antibody [FITC-labeled goat anti-mouse IgG or Tex-
as-Red-labeled goat anti-rabbit IgG (Jackson Laboratory,
Bar Harbor, Maine)] were added to the cells for 30 min,
and the cells washed in PBS/Saponin. Fluorescence was
examined using a Nikon FXA fluorescent microscope
(Nikon Corp., Tokyo, Japan) and appropriate filter sets.
Flow cytometry
rSV5 and rSV5DSH virus-infected CV-1 cells at 18 h p.i.
were washed three times with PBS deficient in calcium
and magnesium and containing 0.02% sodium azide
(PBS–FACS). The cells were incubated for 30 min on ice
with mAb F1a (1:1000 dilution of ascites fluid) and rabbit
a-HN polyclonal antibody (1:300 dilution). The cells were
then washed with PBS–FACS as described above and
incubated with FITC-conjugated goat anti-rabbit IgG and
Texas-Red-conjugated goat anti-mouse IgG for 30 min.
The cells were washed a further three times with PBS–
FACS and fixed in 0.5% formaldehyde. F- and HN-specific
fluorescence was measured on 10,000 cells using a
FACSCalibur flow cytometer (Becton-Dickinson, San
Jose, CA).
Cell fusion assays
Lipid mixing fusion assay. The lipid mixing fusion as-
say using octadecyl rhodamine (R18) was performed
essentially as described previously (Morris et al., 1989).
Human red blood cells were labeled with R18 as de-
scribed (Bagai and Lamb, 1995). CV-1 cells on coverslips
in 6-cm-diameter plates were infected with rSV5 and
rSV5DSH at a m.o.i. of 3 pfu/cell, and at 18 h p.i. the cells
were washed three times with PBS and incubated for 1 h
at 37°C with 1 ml neuraminidase (50 mU/ml, Sigma
Chemical Co., St. Louis, MO). The cells were washed
three times with ice cold PBS, and 3 ml of 0.1% R18-
labeled RBCs was added to the cells and incubated on
ice for 30 min with gentle shaking at 10-min intervals.
The cells were then washed six times to remove un-
bound RBCs. To activate fusion, the cells were incubated
at 37°C for different lengths of time. R18 fluorescence
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was observed and recorded using a confocal micro-
scope (Zeiss LSM410, Zeiss Inc, Thornwood, NY).
Cytoplasmic content mixing. BHK-21F cells in six-well
plates, at approximately 50% confluence were infected
with rSV5 or rSV5DSH for 1 h and then transfected using
LipofectAmine (Gibco-BRL) with 1 mg of pYZ3 [which
contains the gene encoding T7 RNA polymerase under
the control of the late region SV40 promoter (Zhou et al.
1990)]. Concomitantly, BHK-21F cells in 6-cm-diameter
plates were transfected with 2 mg of pBH82, which con-
tains a gene encoding CAT under the control of a T7 RNA
polymerase promoter and a 59 internal ribosomal entry
site from encephalomyocarditis virus (EMCV-IRES) (He et
al., 1995). The cells were incubated in the transfection
mixture for 8–10 h and then trypsinized and overlayed
onto virus-infected, pYZ3-transfected BHK-21F cells. Af-
ter mixing of the two cell populations, the cells were
collected at different time points and CAT activity as-
sayed as described previously (He et al., 1995).
Electron microscopy
rSV5 and rSV5DSH were grown in MDCK cells and
purified on sucrose gradients as described (Paterson
and Lamb, 1993). For electron microscopy, purified viri-
ons were absorbed onto parlodion-coated grids for 30 s,
after which remaining virus suspension was washed off
with PBS as described previously (Jin et al., 1997). Grids
were stained with 2% phosphotungstic acid, (pH 6.6). A
thin layer of carbon was evaporated over the grids prior
to viewing in the electron microscope (Joel 120CX, Tokyo,
Japan).
Immunoblotting
Purified rSV5 and rSV5DSH virus polypeptides were
analyzed by SDS–PAGE on a 17.5% polyacrylamide gel
containing 4 M urea. The polypeptides were transferred
to PVDF membranes by using a semidry transfer (Trans-
blot) apparatus (Bio-Rad Inc., Richmond, CA) and mem-
branes immunoblotted as described previously (Bur-
nette, 1981). Immunoblotting was performed by using
1:1000 dilutions of the a-SH IgG, a-HN mAb HN5a, and
a-V/P mAb Pk. HRP-conjugated antibodies were used as
secondary antibodies. The bound antibodies were de-
tected by enhanced-chemiluminescence with the Super-
Signal Substrate kit (Pierce Inc., Rockford, IL) according
to the manufacturer’s instructions.
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